Delayed Efficacy After Treatment With Lenalidomide or Thalidomide in Patients With Mucosa-Associated Lymphoid Tissue Lymphoma

BACKGROUND. The immunomodulatory drugs (IMiDs) thalidomide and lenalidomide have both been tested for treatment of mucosa-associated lymphoid tissue (MALT) lymphoma, with lenalidomide, in particular, showing promising activity. However, long-term results are missing. Because of the late-onset remiss...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Kiesewetter, Barbara, Troch, Marlene, Mayerhoefer, Marius E., Dolak, Werner, Simonitsch-Klupp, Ingrid, Raderer, Markus
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2016
Assuntos:
Hematologic Malignancies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4709204/
https://ncbi.nlm.nih.gov/pubmed/26621040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0176
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados